Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Tax Provisions (2016 - 2025)

Dexcom (DXCM) has disclosed Tax Provisions for 12 consecutive years, with $73.4 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 23.15% to $73.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $252.1 million through Dec 2025, up 89.83% year-over-year, with the annual reading at $252.1 million for FY2025, 89.83% up from the prior year.
  • Tax Provisions for Q4 2025 was $73.4 million at Dexcom, up from $68.5 million in the prior quarter.
  • The five-year high for Tax Provisions was $119.7 million in Q3 2023, with the low at -$61.2 million in Q1 2022.
  • Average Tax Provisions over 5 years is $32.2 million, with a median of $42.1 million recorded in 2022.
  • Peak annual rise in Tax Provisions hit 18800.0% in 2021, while the deepest fall reached 708.0% in 2021.
  • Over 5 years, Tax Provisions stood at $11.7 million in 2021, then skyrocketed by 253.85% to $41.4 million in 2022, then tumbled by 124.4% to -$10.1 million in 2023, then soared by 690.1% to $59.6 million in 2024, then rose by 23.15% to $73.4 million in 2025.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $73.4 million, $68.5 million, and $61.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.